Thailand · Delayed Price · Currency is THB Healthlead PCL Statistics
Total Valuation
Healthlead PCL has a market cap or net worth of THB 1.87 billion. The enterprise value is 1.66 billion.
| Market Cap | 1.87B |
| Enterprise Value | 1.66B |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | Mar 14, 2025 |
Share Statistics
Healthlead PCL has 259.25 million shares outstanding. The number of shares has decreased by -0.62% in one year.
| Current Share Class | 259.29M |
| Shares Outstanding | 259.25M |
| Shares Change (YoY) | -0.62% |
| Shares Change (QoQ) | -1.51% |
| Owned by Insiders (%) | 72.37% |
| Owned by Institutions (%) | 0.31% |
| Float | 71.66M |
Valuation Ratios
The trailing PE ratio is 23.96.
| PE Ratio | 23.96 |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | 15.91 |
| P/OCF Ratio | 12.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.38, with an EV/FCF ratio of 14.18.
| EV / Earnings | 20.49 |
| EV / Sales | 0.75 |
| EV / EBITDA | 8.38 |
| EV / EBIT | 15.07 |
| EV / FCF | 14.18 |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.63 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 2.62 |
| Interest Coverage | 6.75 |
Financial Efficiency
Return on equity (ROE) is 8.34% and return on invested capital (ROIC) is 11.67%.
| Return on Equity (ROE) | 8.34% |
| Return on Assets (ROA) | 4.60% |
| Return on Invested Capital (ROIC) | 11.67% |
| Return on Capital Employed (ROCE) | 8.74% |
| Weighted Average Cost of Capital (WACC) | 5.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | 1.49 |
| Inventory Turnover | 5.35 |
Taxes
In the past 12 months, Healthlead PCL has paid 18.29 million in taxes.
| Income Tax | 18.29M |
| Effective Tax Rate | 18.38% |
Stock Price Statistics
The stock price has decreased by -18.18% in the last 52 weeks. The beta is 0.27, so Healthlead PCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -18.18% |
| 50-Day Moving Average | 6.95 |
| 200-Day Moving Average | 7.05 |
| Relative Strength Index (RSI) | 59.20 |
| Average Volume (20 Days) | 113,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healthlead PCL had revenue of THB 2.23 billion and earned 81.23 million in profits. Earnings per share was 0.30.
| Revenue | 2.23B |
| Gross Profit | 570.11M |
| Operating Income | 110.38M |
| Pretax Income | 99.52M |
| Net Income | 81.23M |
| EBITDA | 159.17M |
| EBIT | 110.38M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 509.96 million in cash and 307.32 million in debt, with a net cash position of 202.64 million or 0.78 per share.
| Cash & Cash Equivalents | 509.96M |
| Total Debt | 307.32M |
| Net Cash | 202.64M |
| Net Cash Per Share | 0.78 |
| Equity (Book Value) | 973.06M |
| Book Value Per Share | 3.65 |
| Working Capital | 623.88M |
Cash Flow
In the last 12 months, operating cash flow was 151.34 million and capital expenditures -34.01 million, giving a free cash flow of 117.33 million.
| Operating Cash Flow | 151.34M |
| Capital Expenditures | -34.01M |
| Free Cash Flow | 117.33M |
| FCF Per Share | 0.45 |
Margins
Gross margin is 25.55%, with operating and profit margins of 4.95% and 3.64%.
| Gross Margin | 25.55% |
| Operating Margin | 4.95% |
| Pretax Margin | 4.46% |
| Profit Margin | 3.64% |
| EBITDA Margin | 7.13% |
| EBIT Margin | 4.95% |
| FCF Margin | 5.26% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 2.38%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 2.38% |
| Dividend Growth (YoY) | 13.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 56.93% |
| Buyback Yield | 0.62% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 4.35% |
| FCF Yield | 6.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healthlead PCL has an Altman Z-Score of 4.81 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.81 |
| Piotroski F-Score | 7 |